Cargando…
Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer
The use of immune adjuvants such as toll-like receptor (TLR) agonists reflects a novel strategy in prostate cancer (PCa) therapy. However, interleukin-1 receptor associated kinase 1 (IRAK1), a central effector of TLR signaling, has been shown to be responsible for resistance to radiation-induced tum...
Autores principales: | Schagdarsurengin, Undraga, Breiding, Vanessa, Loose, Maria, Wagenlehner, Florian, Dansranjav, Temuujin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549294/ https://www.ncbi.nlm.nih.gov/pubmed/36226067 http://dx.doi.org/10.3389/fonc.2022.991368 |
Ejemplares similares
-
Post‐prostatic‐massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate‐cancer‐typical microRNAs and activate proto‐oncogenes
por: Schneider, Laura, et al.
Publicado: (2022) -
Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4
por: Schagdarsurengin, Undraga, et al.
Publicado: (2017) -
Targeting Host Tyrosine Kinase Receptor EPHA2 Signaling Affects Uropathogen Infection in Human Bladder Epithelial Cells
por: Prakash, Prema S., et al.
Publicado: (2022) -
Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS
por: Nesheim, Nils, et al.
Publicado: (2018) -
PD-L1 Up-Regulation in Prostate Cancer Cells by Porphyromonas gingivalis
por: Groeger, Sabine, et al.
Publicado: (2022)